Two-year outcomes in patients after hospitalization for COVID-19: data from the TARGET-VIP registry

Two-year outcomes in patients after hospitalization for COVID-19: data from the TARGET-VIP registry

Aim. To evaluate 24-month outcomes after hospital treatment of patients with coronavirus disease 2019 (COVID-19) in a prospective registry.Material and methods. Two-year outcomes (2,2±0,5) after hospital treatment for COVID-19 were analyzed in 802 patients (mean age, 59,8±14,5 years, men, 51,0%). We...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. M. Lukyanov, E. Yu. Andreenko, S. Yu. Martsevich, N. P. Kutishenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Pulin, А. А. Smirnov, V. G. Klyashtorny, O. E. Karpov, O. M. Drapkina
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2023-11-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	coronavirus disease 2019 covid-19 registry prospective follow-up long-term outcomes vaccination cardiovascular diseases chronic non-cardiovascular diseases comorbidity
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/3757
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Long-term outcomes in patients after COVID-19: data from the TARGET-VIP registry
by: M. M. Lukyanov, et al.
Published: (2022-04-01)

Dynamics of age characteristics and prevalence of concomitant cardiovascular and non-sardiovascular diseases in patients hospitalized with COVID-19 during epidemic wave: data from TARGET-VIP registry
by: M. M. Lukyanov, et al.
Published: (2022-01-01)

Medical treatment of cardiovascular diseases in patients after hospitalization for COVID-19 (three-year follow-up data in the TARGET-VIP registry)
by: N. P. Kutishenko, et al.
Published: (2025-01-01)

Prospective in-hospital registry of patients with suspected or documented COVID-19 infection and community-acquired pneumonia (TARGET-VIP): characteristics of patients and assessment of in-hospital outcomes
by: O. M. Drapkina, et al.
Published: (2020-12-01)

Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19
by: N. P. Kutishenko, et al.
Published: (2023-01-01)

Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19
by: A. A. Smirnov, et al.
Published: (2022-11-01)

Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data)
by: S. Yu. Martsevich, et al.
Published: (2022-01-01)

Early cardiovascular multimorbidity in out- and in-patient care: age characteristics and medication therapy (data from the REKVAZA and REKVAZA-CLINIC registries)
by: E. Yu. Andreenko, et al.
Published: (2020-11-01)

THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT?
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

Remote outcomes in patients with cardiovascular diseases in outpatient practice: data from a 10-year follow-up within the RECVAZA registry
by: M. M. Luk'yanov, et al.
Published: (2025-02-01)

Outpatient-Polyclinic Register of the Multidisciplinary Medical Center (TERRA): general characteristics and first results
by: M. M. Lukyanov, et al.
Published: (2023-07-01)

Young ambulatory patients with cardiovascular diseases: age and gender characteristics, comorbidity, medication and outcomes (according to RECVASA register)
by: E. Yu. Andreenko, et al.
Published: (2019-12-01)

REGISTERS IN CARDIOLOGY: THEIR PRINCIPLES, RULES, AND REAL-WORD POTENTIAL
by: S. A. Boytsov, et al.
Published: (2013-02-01)

Patients with Premature Cardiovascular Diseases in Ambulatory Practice: Demographic Characteristics, Risk Factors and Adherence to the Medical Therapy (Data of RECVASA Registry)
by: E. Yu. Andreenkо, et al.
Published: (2020-05-01)

REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION"
by: S. Yu. Martsevich, et al.
Published: (2016-06-01)

CARDIOVASCULAR DISEASES REGISTRY (RECVAZA): DIAGNOSTICS, CONCOMITANT CARDIOVASCULAR PATHOLOGY, COMORBIDITIES AND TREATMENT IN THE REAL OUTPATIENT-POLYCLINIC PRACTICE
by: S. A. Boytsov, et al.
Published: (2014-12-01)

THE OUTPATIENT BASED REGISTRY RECVASA: PROSPECTIVE FOLLOW-UP DATA, RISK EVLUATION AND OUTCOMES IN CARDIOVASCULAR PATIENTS
by: S. A. Boytsov, et al.
Published: (2015-02-01)

SEASONAL AND MONTHLY CHANGES OF MORTALITY IN RUSSIAN FEDERATION REGIONS WITH DIFFERENT CLIMATE AND GEOGRAPHIC VARIABLES
by: A. V. Kontsevaya, et al.
Published: (2014-11-01)

Standard transthoracic echocardiography. Guidelines 2024
by: S. T. Matskeplishvili, et al.
Published: (2025-03-01)

Self-monitoring and treatment of chronic non-communicable diseases in the context of the COVID-19 pandemic. Consensus of experts of the National society of evidence-based pharmacotherapy and the Russian society of the prevention of non-communicable diseases
by: S. Yu. Martsevich, et al.
Published: (2020-07-01)

Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization
by: Yu. V. Mareev, et al.
Published: (2023-01-01)

Medication adherence of cardiovascular patients after COVID-19: 6-month follow-up
by: A. R. Tyapaeva, et al.
Published: (2024-04-01)

Cardiovascular mortality rate in Moscow and St. Petersburg in 2015 and 2018
by: S. A. Boytsov, et al.
Published: (2021-02-01)

Cardiovascular risk management system: prerequisites for developing, organization principles, target groups
by: E. V. Shlyakhto, et al.
Published: (2019-11-01)

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES IN PATIENTS WITH DIABETES AND PREDIABETES (2021)
by: I. E. Chazova, et al.
Published: (2021-05-01)

Refusal of pharmacological treatment: prevalence and clinical importance
by: S. Yu. Martsevich, et al.
Published: (2025-06-01)

Associations of neighborhood infrastructure with cardiovascular diseases and their risk factors: results of the ESSE-RF-3 epidemiological study
by: S. A. Maksimov, et al.
Published: (2025-02-01)

Treatment of Patients Chronic Coronary Heart Disease and Type 2 Diabetes Mellitus
by: E. V. Shсhukina, et al.
Published: (2023-04-01)

THE RELATION OF ALCOHOL CONSUMPTION WITH CARDIOVASCULAR DISEASES AND RISK FACTORS (ESSE-RF TRIAL IN KEMEROVSKAYA OBLAST)
by: S. A. Maksimov, et al.
Published: (2017-10-01)

Anemia of chronic diseases: connection with cardiovascular pathology
by: S. A. Nedomolkina, et al.
Published: (2024-12-01)

STATISTICAL, CLINICAL AND MORPHOLOGICAL CLASSIFICATIONS OF CORONARY HEART DISEASE — POSSIBLE TO UNITE?
by: S. A. Boytsov, et al.
Published: (2017-03-01)

Cardiovascular risk factors in patients with calcium pyrophosphate crystal deposition disease
by: M. S. Eliseev, et al.
Published: (2019-11-01)

A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases
by: Yu. V. Bulaeva, et al.
Published: (2021-11-01)

THE PREVALENCE OF NON-INFECTIOUS DISEASES RISK FACTORS IN RUSSIAN POPULATION IN 2012-2013 YEARS. THE RESULTS OF ECVD-RF
by: G. A. Muromtseva, et al.
Published: (2014-12-01)

FEATURES OF SEASONAL CARDIOVASCULAR MORTALITY IN WINTER IN RUSSIAN REGIONS WITH DIFFERENT CLIMATIC AND GEOGRAPHICAL CHARACTERISTICS
by: S. A. Boytsov, et al.
Published: (2015-09-01)

Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues
by: M. V. Zhuravleva, et al.
Published: (2020-09-01)

DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT
by: N. В. Perepech, et al.
Published: (2018-05-01)

Dynamics of disability in the adult population of the Astrakhan region due to diseases of the cardiovascular system over 2016–2022
by: E. B. Starodubova, et al.
Published: (2024-09-01)

Body weight and cardiovascular disease prevalence in climacteric women
by: N. V. Izmozherova, et al.
Published: (2006-04-01)

Associations of cardiovascular diseases and type 2 diabetes with ophthalmic diseases in a population sample over 55 years old
by: A. O. Direev, et al.
Published: (2021-11-01)